Clinical cases where lesion therapy was chosen over deep brain stimulation

Stereotactic and Functional Neurosurgery

Volumn 86, Issue 3, 2008, Pages 147-152

  Hooper, Amanda K ^a   Okun, Michael S ^a   Foote, Kelly D ^a   Fernandez, Hubert H ^a   Jacobson, Charles ^a   Zeilman, Pamela ^a   Romrell, Janet ^a   Rodriguez, Ramon L ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Lesion therapy; Subthalamotomy; Thalamotomy

Indexed keywords

BENZATROPINE; BIPERIDEN; CARBIDOPA; CLONAZEPAM; DIAZEPAM; ETIRACETAM; GABAPENTIN; LEVODOPA; LORAZEPAM; OXAZEPAM; PRIMIDONE; PROPRANOLOL DERIVATIVE; RISPERIDONE; ROPINIROLE; TOPIRAMATE;

ADULT; AGED; ANAMNESIS; ARTICLE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CASE REPORT; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; DAILY LIFE ACTIVITY; DEBRIDEMENT; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; ESSENTIAL TREMOR; FEMALE; FOLLOW UP; HUMAN; IMMUNE STATUS; INFECTION RISK; INTERMETHOD COMPARISON; MALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; THALAMOTOMY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGED, 80 AND OVER; DEEP BRAIN STIMULATION; ESSENTIAL TREMOR; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; PALLIDOTOMY; PARKINSON DISEASE; STEREOTAXIC TECHNIQUES;

EID: 43649098436     PISSN: 10116125     EISSN: None     Source Type: Journal    
DOI: 10.1159/000120426     Document Type: Article

References (61)

1. Tsubokawa T, Katatama Y: Lesion-making surgery versus brain stimulation for treatment of Parkinson's disease. Crit Rev Neurosurg 1999;9:96-106.
2. Tan EK: Parkinson's disease surgery: advances and future strategies. Int J Clin Pract 1999;53:623-626.
3. Tasker RR, Munz M, Junn FS, Kiss ZH, Davis K, Dostrovsky JO, Lozano AM: Deep brain stimulation and thalamotomy for tremor compared. Acta Neurochir Suppl 1997;68:49-53.
4. Okun MS, Vitek JL: Lesion therapy for Parkinson's disease and other movement disorders: update and controversies. Mov Disord 2004;19:375-389.
5. Olanow CW: Surgical therapy for Parkinson's disease. Eur J Neurol 2002;9(suppl 3):31-39.
6. Olanow CW, Brin MF, Obeso JA: The role of deep brain stimulation as a surgical treatment for Parkinson's disease. Neurology 2000;55(suppl 6):S60-S66.
7. Kumar K, Kelly M, Toth C: Deep brain stimulation of the ventral intermediate nucleus of the thalamus for control of tremors in Parkinson's disease and essential tremor. Stereotact Funct Neurosurg 1999;72:47-61.
8. Katayama Y, Kano T, Kobayashi K, Oshima H, Fukaya C, Yamamoto T: Difference in surgical strategies between thalamotomy and thalamic deep brain stimulation for tremor control. J Neurol 2005;252(suppl 4):IV17-IV22.
9. Kiss ZH, Wilkinson M, Krcek J, Suchowersky O, Hu B, Murphy WF, Hobson D, Tasker RR: Is the target for thalamic deep brain stimulation the same as for thalamotomy? Mov Disord 2003;18:1169-1175.
10. Jimenez F, Velasco F, Carrillo-Ruiz JD, Garcia L, Madrigal A, Velasco AL, Marquez I: Comparative evaluation of the effects of unilateral lesion versus electrical stimulation of the globus pallidus internus in advanced Parkinson's disease. Stereotact Funct Neurosurg 2006;84:64-71.
11. Duff J, Sime E: Surgical interventions in the treatment of Parkinson's disease (PD) and essential tremor (ET): medial pallidotomy in PD and chronic deep brain stimulation (DBS) in PD and ET. Axone 1997;18:85-89.
12. Anonymous. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
13. Ackermans L, Temel Y, Cath D, van der Linden C, Bruggeman R, Kleijer M, Nederveen P, Schruers K, Colle H, Tijssen MA, Visser-Vandewalle V: Deep brain stimulation in Tourette's syndrome: two targets? Mov Disord 2006;21:709-713.
14. Diederich NJ, Kalteis K, Stamenkovic M, Pieri V, Alesch F: Efficient internal pallidal stimulation in Gilles de la Tourette syndrome: a case report. Mov Disord 2005;20:1496-1499.
15. Flaherty AW, Williams ZM, Amirnovin R, Kasper E, Rauch SL, Cosgrove GR, Eskandar EN: Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery 2005;57:E403; discussion E403.
16. Gallagher CL, Garell PC, Montgomery EB, Jr: Hemi tics and deep brain stimulation. Neurology 2006;66:E12.
17. Greenberg BD, Price LH, Rauch SL, Friehs G, Noren G, Malone D, Carpenter LL, Rezai AR, Rasmussen SA: Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. Neurosurg Clin N Am 2003;14:199-212.
18. Lang AE: Surgery for levodopa-induced dyskinesias. Ann Neurol 2000;47(suppl 1):S193-S199; discussion S199-S202.
19. Mink JW, Walkup J, Frey KA, Como P, Cath D, Delong MR, Erenberg G, Jankovic J, Juncos J, Leckman JF, Swerdlow N, Visser-Vandewalle V, Vitek JL: Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord 2006;21:1831-1838.
20. Skidmore FM, Rodriguez RL, Fernandez HH, Goodman WK, Foote KD, Okun MS: Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders. CNS Spectr 2006;11:521-536.
21. Temel Y, Visser-Vandewalle V: Surgery in Tourette syndrome. Mov Disord 2004;19:3-14.
22. Visser-Vandewalle V, Ackermans L, van der Linden C, Temel Y, Tijssen MA, Schruers KR, Nederveen P, Kleijer M, Boon P, Weber W, Cath D: Deep brain stimulation in Gilles de la Tourette's syndrome. Neurosurgery 2006;58:E590.
23. Visser-Vandewalle V, Temel Y, van der Linden C, Ackermans L, Beuls E: Deep brain stimulation in movement disorders. The applications reconsidered. Acta Neurol Belg 2004;104:33-36.
24. Vonck K, Boon P, Goossens L, Dedeurwaerdere S, Claeys P, Gossiaux F, Van Hese P, De Smedt T, Raedt R, Achten E, Deblaere K, Thieleman A, Vandemaele P, Thiery E, Vingerhoets G, Miatton M, Caemaert J, Van Roost D, Baert E, Michielsen G, Dewaele F, Van Laere K, Thadani V, Robertson D, Williamson P: Neurostimulation for refractory epilepsy. Acta Neurol Belg 2003;103:213-217.
25. Velasco L, Jimenez F, Perez ML, Carrillo-Ruiz JD, Velasco AL, Ceballos J, Velasco M: Electrical stimulation of the prelemniscal radiation in the treatment of Parkinson's disease: An old target revised with new techniques. Neurosurgery 2001;49:293-306; discussion 306-308.
26. Alvarez L, Macias R, Lopez G, Alvarez E, Pavon N, Rodriguez-Oroz MC, Juncos JL, Maragoto C, Guridi J, Litvan I, Tolosa ES, Koller W, Vitek J, DeLong MR, Obeso JA: Bilateral subthalamotomy in Parkinson's disease: initial and long-term response. Brain 2005;128:570-583.
27. Gill SS, Heywood P: Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet 1997;350:1224.
28. Blomstedt P, Hariz MI: Are complications less common in deep brain stimulation than in ablative procedures for movement disorders? Stereotact Funct Neurosurg 2006;84:72-81.
29. Walter BL, Vitek JL: Surgical treatment for Parkinson's disease. Lancet Neurol 2004;3:719-728.
30. Blomstedt P, Hariz MI: Hardware-related complications of deep brain stimulation: a ten-year experience. Acta Neurochir (Wien) 2005;147:1061- 1064;discussion 1064.
31. Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, Lyons KE, Rodriguez-Oroz MC, Tamma F, Troster AI, Vitek JL, Volkmann J, Voon V: Deep brain stimulation: postoperative issues. Mov Disord 2006;21(suppl 14):S219-S237.
32. Hariz MI: Complications of deep brain stimulation surgery. Mov Disord 2002;17(suppl 3):S162-S166.
33. Kondziolka D, Whiting D, Germanwala A, Oh M: Hardware-related complications after placement of thalamic deep brain stimulator systems. Stereotact Funct Neurosurg 2002;79:228-233.
34. Oh MY, Abosch A, Kim SH, Lang AE, Lozano AM: Long-term hardware-related complications of deep brain stimulation. Neurosurgery 2002;50:1268-1274; discussion 1274-1266.
35. Temel Y, Ackermans L, Celik H, Spincemaille GH, van der Linden C, Walenkamp GH, van de Kar T, Visser-Vandewalle V: Management of hardware infections following deep brain stimulation. Acta Neurochir (Wien) 2004;146:355-361; discussion 361.
36. Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH: Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg 2003;98:779-784.
37. Voges J, Waerzeggers Y, Maarouf M, Lehrke R, Koulousakis A, Lenartz D, Sturm V: Deep-brain stimulation: long-term analysis of complications caused by hardware and surgery - experiences from a single centre. J Neurol Neurosurg Psychiatry 2006;77:868-872.
38. Imam I: The neurology of HIV infection - a review of the literature. Niger J Med 2005;14:121-131.
39. Mielke J: Neurological complications of human immunodeficiency virus infection in Zimbabwe 2005. J Neurovirol 2005;11(suppl 3):23-25.
40. Moulignier A: Hiv and the central nervous system (French). Rev Neurol 2006;162:22-42.
41. Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G: Outcome of aids-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. BMC Infect Dis 2006;6:118.
42. Sher R: Aids and related conditions - infection control. Guidelines for health care workers involved in patient management and investigation. S Afr Med J 1985;68:843-848.
43. Hunka K, Suchowersky O, Wood S, Derwent L, Kiss ZH: Nursing time to program and assess deep brain stimulators in movement disorder patients. J Neurosci Nurs 2005;37:204-210.
44. Ondo WG, Bronte-Stewart H: The North American survey of placement and adjustment strategies for deep brain stimulation. Stereotact Funct Neurosurg 2005;83:142-147.
45. Biousse V, Newman NJ, Carroll C, Mewes K, Vitek JL, Bakay RA, Baron MS, DeLong MR: Visual fields in patients with posterior GPi pallidotomy. Neurology 1998;50:258-265.
46. De Bie RM, Schuurman PR, Esselink RA, Bosch DA, Speelman JD: Bilateral pallidotomy in Parkinson's disease: a retrospective study. Mov Disord 2002;17:533-538.
47. Intemann PM, Masterman D, Subramanian I, DeSalles A, Behnke E, Frysinger R, Bronstein JM: Staged bilateral pallidotomy for treatment of Parkinson disease. J Neurosurg 2001;94:437-444.
48. Lang AE, Lozano A, Tasker R, Duff J, Saint-Cyr J, Trepanier L: Neuropsychological and behavioral changes and weight gain after medial pallidotomy. Ann Neurol 1997;41:834-836.
49. Merello M, Starkstein S, Nouzeilles MI, Kuzis G, Leiguarda R: Bilateral pallidotomy for treatment of Parkinson's disease-induced corticobulbar syndrome and psychic akinesia avoidable by globus pallidus lesion combined with contralateral stimulation. J Neurol Neurosurg Psychiatry 2001;71:611-614.
50. Merello M, Perez-Lloret S, Antico J, Obeso JA: Dyskinesias induced by subthalamotomy in Parkinson's disease are unresponsive to amantadine. J Neurol Neurosurg Psychiatry 2006;77:172-174.
51. Su PC, Tseng HM: Subthalamotomy for end-stage severe Parkinson's disease. Mov Disord 2002;17:625-627.
52. Su PC, Tseng HM, Liu HM, Yen RF, Liou HH: Subthalamotomy for advanced Parkinson disease. J Neurosurg 2002;97:598-606.
53. Bhattacharyya TK, Thomas JR: Histomorphologic changes in aging skin: observations in the CBA mouse model. Arch Facial Plast Surg 2004;6:21-25.
54. Brenner B, Borok S, Rakowsky E, Fenig E, Gutman H, Sulkes J, Sulkes A, Schachter J: Older age and second skin cancer as prognostic factors in localized malignant melanomas. Oncol Rep 2003;10:2051-2057.
55. Forslind B, Lindberg M, Roomans GM, Pallon J, Werner-Linde Y: Aspects on the physiology of human skin: studies using particle probe analysis. Microsc Res Tech 1997;38:373-386.
56. Gilhar A, Ullmann Y, Karry R, Shalaginov R, Assy B, Serafimovich S, Kalish RS: Ageing of human epidermis: the role of apoptosis, Fas and telomerase. Br J Dermatol 2004;150:56-63.
57. Sandby-Moller J, Poulsen T, Wulf HC: Epidermal thickness at different body sites: relationship to age, gender, pigmentation, blood content, skin type and smoking habits. Acta Derm Venereol 2003;83:410-413.
58. Sauermann K, Clemann S, Jaspers S, Gambichler T, Altmeyer P, Hoffmann K, Ennen J: Age-related changes of human skin investigated with histometric measurements by confocal laser scanning microscopy in vivo. Skin Res Technol 2002;8:52-56.
59. Ulger H, Erdogan N, Kumanlioglu S, Unur E: Effect of age, breast size, menopausal and hormonal status on mammographic skin thickness. Skin Res Technol 2003;9:284-289.
60. Raoul S, Faighel M, Rivier I, Verin M, Lajat Y, Damier P: Staged lesions through implanted deep brain stimulating electrodes: a new surgical procedure for treating tremor or dyskinesias. Mov Disord 2003;18:933-938.
61. Oh MY, Hodaie M, Kim SH, Alkhani A, Lang AE, Lozano AM: Deep brain stimulator electrodes used for lesioning: proof of principle. Neurosurgery 2001;49:363-367; discussion 367-369.